CELZ
NASDAQ · Biotechnology
Creative Medical Technology
$2.24
+0.03 (+1.36%)
Open$2.24
Previous Close$2.21
Day High$2.30
Day Low$2.20
52W High$6.25
52W Low$1.50
Volume—
Avg Volume47.8K
Market Cap8.28M
P/E Ratio—
EPS$-2.49
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,390.6% upside
Current
$2.24
$2.24
Target
$33.39
$33.39
$22.85
$33.39 avg
$43.53
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.2K | 22.8K | 749.0K |
| Net Income | -9,300,816 | -20,642,994 | -154,552 |
| Profit Margin | -99,916.8% | -94,921.0% | -20.6% |
| EBITDA | -9,338,522 | -21,878,164 | -155,667 |
| Free Cash Flow | — | — | -141,548 |
| Rev Growth | -59.5% | -59.5% | +1.8% |
| Debt/Equity | — | — | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |